Emergent BioSolutions acquires monoclonal anthrax product candidate

ROCKVILLE, Md. Read More »

Emergent BioSolutions announces start of anthrax treatment trial

ROCKVILLE, Md. Read More »

Government extends deadline for plans to develop anthrax rPA vaccine

ROCKVILLE, Md. Read More »

TB vaccine candidate enters Phase IIb proof-of-concept trial in South Africa

The Aeras Global TB Vaccine Foundation, the Oxford-Emergent Tuberculosis Consortium Ltd., Isis Innovation Ltd., the Wellcome Trust and the University of Cape Town announce the start of a Phase IIb proof-of-concept clinical trial of a new TB vaccine. Read More »

Former DHHS secretary joins board of directors of Emergent BioSolutions


Mich. governor welcomes $75 million vaccine production facility

LANSING, Mich. Read More »

Joint venture aims to develop advanced tuberculosis vaccine

The University of Oxford and Emergent BioSolutions Inc. announced July 23, 2008, that they have formed the Oxford-Emergent Tuberculosis Consortium Ltd. to further develop MVA85A, a vaccine candidate for the prevention of tuberculosis. Read More »

NIAID awards 2 grants to Emergent BioSolutions for vaccine development

Emergent BioSolutions Inc. announced that it has secured two grants totaling more than $4.5 million from the NIAID to fund the continued development of the company Read More »

Emergent BioSolutions submits proposal to develop new anthrax vaccine

ROCKVILLE, Md. Read More »

Another study finds no link between vaccine, autism

NEW YORK Read More »

Leukemia vaccine being developed

LONDON Read More »

China says H1N1 flu spreading into the countryside

BEIJING Read More »

Rise in mumps cases blamed on youngsters missing out on MMR jabs

Cases of mumps in Scotland have increased by almost 50 per cent in the past year, figures revealed Dec. 23. Read More »

H1N1 response shows need for better medical emergency plans

This commentary was written by Bob Graham and Jim Talent ?and published in The Washington Post on Jan. 4. Read More »

3 H1N1 vaccine studies confirm safety, weigh dosing

Large trials in the United States, Hungary and China recently confirmed the safety and efficacy of H1N1 vaccines, yielding new insights on how to best use vaccines in a pandemic setting, CIDRAP News reported Jan. 4. Read More »

Insect cells provide the key to alternative H1N1 flu vaccination

Scientists in Vienna have developed a new technique for producing vaccines for H1N1 based on insect cells, according to a report by ScienceDaily on Jan. 4. Read More »

GeoVax Labs appoints vice president for research, development

ATLANTA Read More »

Gaps in U.S. children's vaccine coverage shrinking

More American children are fully immunized against common childhood illnesses, and disparities in vaccine coverage among socioeconomic groups are shrinking, according to a new study from the Centers for Disease Control and Prevention. Read More »

CDC addresses safety of thimerosal in vaccines against H1N1 flu

The Centers for Disease Control and Prevention posted this Read More »

Cepheid receives FDA emergency use authorization for its flu panel test

SUNNYVALE, Calif. Read More »